HS-101

N/A

Report date: 2024/11/14 15:48:33

First In Class

Base Information

Drug NameHS-101

Drug Alias NameHS-101

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionTransforming growth factor beta stimulantsMothers against decapentaplegic homolog 2 stimulantsMothers against decapentaplegic homolog 3 stimulants

TargetsTransforming growth factor betaMothers against decapentaplegic homolog 2Mothers against decapentaplegic homolog 3

Therapy Area/IndicationsOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHaplnScience Inc

China Registration ClassN/A

Develop Information

Active CompaniesHaplnScience Inc

Inactive CompaniesN/A

Active IndicationsOsteoarthritis

Inactive IndicationsN/A

Other Information

ATC CodeN/A